Signatera Assessment in Early-Stage Endometrial Cancer
Public ClinicalTrials.gov record NCT07339384. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Circulating Tumor DNA Assessment in Early-Stage Endometrial Cancer (SIGNAL-EMC 101)
Study identification
- NCT ID
- NCT07339384
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Natera, Inc.
- Industry
- Enrollment
- 1,010 participants
Conditions and interventions
Conditions
Interventions
- Signatera Genome ultra-sensitive ctDNA blood test Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2026
- Primary completion
- Apr 30, 2034
- Completion
- Apr 30, 2034
- Last update posted
- Apr 21, 2026
2026 – 2034
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham Hospital | Birmingham | Alabama | 35294 | — |
| University of California, San Diego | La Jolla | California | 92093 | — |
| University of California, Los Angeles | Los Angeles | California | 90095 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| New York University | New York | New York | 10016 | — |
| Atrium Health Levine Cancer | Charlotte | North Carolina | 28204 | — |
| Duke University | Durham | North Carolina | 27708 | — |
| Cleveland Clinic | Cleveland | Ohio | 44106 | — |
| Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07339384, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07339384 live on ClinicalTrials.gov.